These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 36658701)
1. Application of Phosphoramidate ProTide Technology for the Synthesis of 5'-mRNA Cap Analogs Modified on the Exocyclic Amine Group. Siekierska I; Lukaszewicz M; Worch R; Jankowska-Anyszka M; Piecyk K ChemMedChem; 2023 Feb; 18(4):e202200490. PubMed ID: 36658701 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-herpetic activity of phosphoramidate ProTides. Maiti M; Persoons L; Andrei G; Snoeck R; Balzarini J; Herdewijn P ChemMedChem; 2013 Jun; 8(6):985-93. PubMed ID: 23606629 [TBL] [Abstract][Full Text] [Related]
4. An overview of ProTide technology and its implications to drug discovery. Serpi M; Pertusati F Expert Opin Drug Discov; 2021 Oct; 16(10):1149-1161. PubMed ID: 33985395 [No Abstract] [Full Text] [Related]
5. Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells. Mehellou Y; Balzarini J; McGuigan C ChemMedChem; 2009 Nov; 4(11):1779-91. PubMed ID: 19760699 [TBL] [Abstract][Full Text] [Related]
7. New Heights for ProTides? Ballatore C J Med Chem; 2021 Nov; 64(22):16422-16424. PubMed ID: 34783565 [TBL] [Abstract][Full Text] [Related]
8. N2 modified cap analogues as translation inhibitors and substrates for preparation of therapeutic mRNA. Kurpiejewski K; Jankowska-Anyszka M; Grzela R Eur Biophys J; 2023 Oct; 52(6-7):511-519. PubMed ID: 37656232 [TBL] [Abstract][Full Text] [Related]
9. The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479). McGuigan C; Kelleher MR; Perrone P; Mulready S; Luoni G; Daverio F; Rajyaguru S; Le Pogam S; Najera I; Martin JA; Klumpp K; Smith DB Bioorg Med Chem Lett; 2009 Aug; 19(15):4250-4. PubMed ID: 19505826 [TBL] [Abstract][Full Text] [Related]
11. Could 5'-N and S ProTide analogues work as prodrugs of antiviral agents? Procházková E; Hřebabecký H; Dejmek M; Šála M; Šmídková M; Tloušťová E; Zborníková E; Eyer L; Růžek D; Nencka R Bioorg Med Chem Lett; 2020 Feb; 30(4):126897. PubMed ID: 31882298 [TBL] [Abstract][Full Text] [Related]
12. The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virus. McGuigan C; Perrone P; Madela K; Neyts J Bioorg Med Chem Lett; 2009 Aug; 19(15):4316-20. PubMed ID: 19523820 [TBL] [Abstract][Full Text] [Related]
16. An AZT Analog with Strongly Pairing Ethynylpyridone Nucleobase and Its Antiviral Activity against HSV1. Han J; Funk C; Eyberg J; Bailer S; Richert C Chem Biodivers; 2021 Jan; 18(1):e2000937. PubMed ID: 33270983 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of purine 2'-fluoro-2'-deoxyriboside ProTides as anti-influenza virus agents. Meneghesso S; Vanderlinden E; Brancale A; Balzarini J; Naesens L; McGuigan C ChemMedChem; 2013 Mar; 8(3):415-25. PubMed ID: 23386468 [TBL] [Abstract][Full Text] [Related]
18. Triazole-containing monophosphate mRNA cap analogs as effective translation inhibitors. Piecyk K; Lukaszewicz M; Darzynkiewicz E; Jankowska-Anyszka M RNA; 2014 Oct; 20(10):1539-47. PubMed ID: 25150228 [TBL] [Abstract][Full Text] [Related]
19. Reactive cyclic intermediates in the ProTide prodrugs activation: trapping the elusive pentavalent phosphorane. Procházková E; Navrátil R; Janeba Z; Roithová J; Baszczyňski O Org Biomol Chem; 2019 Jan; 17(2):315-320. PubMed ID: 30543240 [TBL] [Abstract][Full Text] [Related]
20. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside. Perrone P; Luoni GM; Kelleher MR; Daverio F; Angell A; Mulready S; Congiatu C; Rajyaguru S; Martin JA; Levêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C J Med Chem; 2007 Apr; 50(8):1840-9. PubMed ID: 17367121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]